New Developments and Challenges in Antibody-Based Therapies for the Respiratory Syncytial Virus

Since the discovery of the human respiratory syncytial virus (hRSV), multiple research efforts have been conducted to develop vaccines and treatments capable of reducing the risk of severe disease, hospitalization, long-term sequelae, and death from this pathogen in susceptible populations. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Diethelm-Varela, Benjamín, Soto, Jorge A, Riedel, Claudia A, Bueno, Susan M, Kalergis, Alexis M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094422/
https://www.ncbi.nlm.nih.gov/pubmed/37063935
http://dx.doi.org/10.2147/IDR.S379660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094422/
https://www.ncbi.nlm.nih.gov/pubmed/37063935
http://dx.doi.org/10.2147/IDR.S379660

Ejemplares similares